Fruits of the Human Genome Project are already transforming health care. Primary care providers, regardless of specialty, will need to integrate new genetics knowledge into routine practice in order to fulfill their role in genetics services delivery. Unfortunately, few are prepared for this revolution, and current educational efforts are inadequate. To effect the changes that are needed, we must teach genetics as an integrative discipline at all stages of professional education and emphasize the value of this knowledge to practice.

1.
Graham JM Jr, Rotter JI, Riccardi VM, Baird PA, Benkendorf J, Bodurtha J, Childs B, Davidson R, Huether CA, Laing K, Murray RF, Nadler H, Nance WE, Nesbitt M, Scriver CR, Short EM, Summitt RL, Toriello HV: Report of the Task Force on Teaching Human Genetics in North American Medical Schools. Am J Human Genet 1989;44:161–165.
2.
Childs B: Genetics in medical education. Am J Hum Genet 1993;52:225–227.
3.
Fulginiti VA: Genetics: The quiet revolution in science and medicine. Implications for research on child health issues, education of health professionals, and the new preventive and curative medicine (editorial). Am J Dis Child 1993;147:1139–1141.
4.
Kershner MA, Hammond EA, Donnenfeld AE: Knowledge of genetics among residents in obstetrics and gynecology. Am J Hum Genet 1993;53:1356–1358.
5.
Lemkus SM, Van der Merwe CF, Op’t Hof J: Genetic and congenital disorders. Knowledge and attitudes of the public, nurses and medical practitioners in South Africa. S Afr Med J 1978;53:491–494.
6.
Hofman KJ, Tambor ES, Chase GA, Geller G, Faden RR, Holtzman NA: Physicians’ knowledge of genetics and genetic tests. Acad Med 1993;68:625–632.
7.
Anderson GW: The evolution and status of genetics education in nursing in the United States 1983–1995. Image J Nurs Sch 1996;28:101–106.
8.
Botkin JR: The legal concept of wrongful life. JAMA 1988;259:1541–1545.
9.
Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG: Assessing Genetic Risks: Implications for Health and Social Policy. Washington, National Academy Press, 1994, p 338.
10.
Harris R, Harris H: Genetics in primary care. Report on workshop of EC Concerted Action on Genetics Services in Europe (CAGSE) in association with the Royal College of GP Spring Meeting, Blackpool, UK, 28 April 1995. J Med Genet 1996;33:346–348.
11.
Hayflick SJ, Silvey K, Eiff MP: The role of primary care providers in the delivery of genetics services. Am J Hum Genet 1997;61:A2281.
12.
Hall J, Powers E, McIlnaine R, Ean V: The frequency and familial burden of genetic disease in a paediatric hospital. Am J Med Genet 1978;1:416–436.
13.
Anonymous: ACOG educational bulletin. Maternal serum screening. Number 228, September 1996 (replaces no. 154, April 1991). Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996;55:299–308.
14.
Friedman JM: Association of professors of human or medical genetics: Summary of first annual workshop. Am J Med Genet 1996;65:235–240.
15.
Friedman JM: Association of Professors of Human or Medical Genetics: Second annual workshop summary. Am J Med Genet 1997;72:191–196.
16.
Baird PA: Toward an ideal human genetics curriculum in medical schools. Am J Hum Genet 1989;44:166–167.
17.
Anonymous: ASHG Report. Report from the ASHG Information and Education Committee: Medical school core curriculum in genetics. ASHG Information and Education Committee (see comments). Am J Hum Genet 1995;56:535–537.
18.
Hayflick SJ: Medical school core curriculum in genetics (letter; comment). Am J Hum Genet 1995;57:1514–1515.
19.
Naylor EW: Genetic screening and genetic counseling: Knowledge, attitudes, and practices in two groups of family planning professionals. Soc Biol 1975;22:304–314.
20.
Lippman-Hand A, Cohen DI: Influence of obstetricians’ attitudes on their use of prenatal diagnosis for the detection of Down’s syndrome. Can Med Assoc J 1980;122:1381–1386.
21.
Firth HV, Lindenbaum RH: UK clinicians’ knowledge of and attitudes to the prenatal diagnosis of single gene disorders. J Med Genet 1992;29:20–23.
22.
Geller G, Tambor ES, Bernhardt BA, Chase GA, Hofman KJ, Faden RR, Holtzman NA: Physicians’ attitudes toward disclosure of genetic information to third parties. J Law Med Ethics 1993;21:238–240.
23.
Geller G, Tambor ES, Chase GA, Hofman KJ, Faden RR, Holtzman NA: Incorporation of genetics in primary care practice. Will physicians do the counseling and will they be dirctive? (see comments). Arch Fam Med 1993;2:1119–1125.
24.
Holtzman NA: Primary care physicians as providers of frontline genetic services. Fetal Diagn Ther 1993;8(suppl 1):213–219.
25.
Faden RR, Tambor ES, Chase GA, Geller G, Hofman KJ, Holtzman NA: Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening. American J Med Genet 1994;50:1–11.
26.
Hem E, van der Hagen CB, Solaas MH: Genetic disease in general practice. An interview study among general practitioners in Oppland and Oslo. Tidsskr Nor Laegeforen 1994;114:1056–1057.
27.
Nomura S, Kawai S, Fukushima T, Katoh H, Osawa G: The attitude of Japanese physicians regarding genetic service for autosomal dominant polycystic kidney disease (ADPKD). Jap J Hum Genet 1994;39:427–431.
28.
Rowley PT, Loader S, Sutera CJ, Kozyra A: Prenatal genetic counseling for hemoglobinopathy carriers: A comparison of primary providers of prenatal care and professional genetic counselors. Am J Hum Genet 1995;56:769–776.
29.
Stratakis CA, Cavuto NJ, Nelson D, Rennert OM: Molecular genetics in pediatric training: How much do we really know? Maryland Med J 1995;44:210–213.
30.
Fibison WJ: The nursing perspective: Genetic screening and testing. J Sch Nurs 1993;9:16–21, 23–24.
31.
Thomson EJ: Reproductive genetic testing: Implications for nursing education. Fetal Diagn Ther 1993;8(suppl 1):232–235.
32.
McElhinney T, Lajkowicz C: The new genetics and nursing education. Nurs Health Care 1994;15:528–531.
33.
Monsen RB: Nursing takes leading role in genetics education: coalition formed to increase provider awareness on genetics technologies. Am Nurse 1996;28:11.
34.
Skirton H, Barnes C, Curtis G, Walford-Moore J: The role and practice of the genetic nurse: Report of the AGNC Working Party. J Med Genet 1997;34:141–147.
35.
Chermak GD, Wagner-Bitz CJ: Survey of speech-language pathologists’ and audiologists’ knowledge of clinical genetics (see comments). ASHA 1993;35:39–45.
36.
Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ: Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995;98:464–468.
37.
Gronbaek KE, Milman N, Skodt V: Preclinical hereditary hemochromatosis – is there an indication for preventive screening? Ugeskrift Laeger 1995;157:4249–4250.
38.
Cartabellotta A, Montalto G: Genetic hemochromatosis: Importance of population screening? Recenti Prog Med 1996;87:118–123.
39.
Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139–200.
40.
McDonnell S, Grummer-Strawn L, Trowbridge F: Screening and early detection of hemochromatosis (letter; comment). Am Fam Phys 1997;55:440–442.
41.
Takeuchi T, Soejima H, Faed JM, Yun K: Efficient large-scale screening for the hemochromatosis susceptibility gene mutation (letter). Blood 1997;90:2848–2849.
42.
Charvet-Protat S, Yaouanq J, Fleurette F: Should we screen for hemochromatosis? Critical analysis of the literature. Revue Epidémiol Santé Publique 1997;45:315–327.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.